Similarly, in the A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes (SOUL) study, which randomized patients with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both to oral semaglutide versus placebo, the primary outcome of major adverse cardiovascular event occurred in 12.0% of the patients receiving semaglutide and 13.8% of the patients receiving placebo (hazard ratio, 0.86
J Nutr 1995;125(3 Suppl):777S783S
1,94% no grupo retratutida 12 mg/semana e 0,81% no grupo placebo
Here are 5 benefits of glutathione: Slows the aging process Fights free radicals Reduces inflammation and cellular damage Assists with memory and mental clarity May help with autoimmune & insulin disorders Glutathione levels can naturally decline as part of the aging process
While more research is needed, it may lower the risk of heart disease in the long term